Featured Stories
#MedSafetyWeek – Every Report Counts and Can Help Others in the Future
Medis regularly encourages its employees to provide the necessary information from the market to ensure the best treatment options for our patients.
Read More
First-Hand Experience with Imunoglukan – Story of Nadja
For Nadja Ott, a pharmacist and Brand Manager, this period at Medis is very stressful, but at the same time, it is also exciting.
Read More
Medis Proudly Announces a New Partnership with Biocodex Nordics
Exclusive distribution agreement for Medis’ latest development Ladiva, which will be commercialized by Biocodex Nordics in Finland, represents a new important...
Read More
A new partnership with Neurim Pharmaceuticals Ltd.
Our exclusive distribution agreement for the commercialization of Slenyto® represents an important milestone for both companies.
Read More
Periodontitis – A War on Teeth and Immune System
The known disease of periodontal tissue does not only cause loss of teeth, but impacts the immune system as well.
Read More
Do not let the statistics bury hope!
What kind of a mark does cancer leave on men and what is the role of their women when facing the disease? Why are oncological diseases still stigmatized and why...
Read More